| NCT07751159 |
Radiation Therapy Approaches for People With Prostate Cancer |
| NCT06848348 |
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain |
| NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
| NCT03424850 |
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy |
| NCT07492680 |
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) |
| NCT06504147 |
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery |
| NCT05983276 |
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer |
| NCT07182279 |
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer |
| NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
| NCT05487846 |
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation |
| NCT05020574 |
Microbiome and Association With Implant Infections |
| NCT06574880 |
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer |
| NCT07023289 |
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease |
| NCT06865768 |
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique |
| NCT06815497 |
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer |
| NCT07647250 |
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy |
| NCT07181161 |
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer |
| NCT07407920 |
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial |
| NCT07644559 |
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer |
| NCT05965180 |
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe |
| NCT05654246 |
Susan G. Komen's ShareForCures |
| NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
| NCT07040891 |
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials |
| NCT06141993 |
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials |
| NCT05413421 |
Study of ORIC-944 in Patients With Metastatic Prostate Cancer |
| NCT07141121 |
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen |
| NCT04997993 |
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer |
| NCT05286814 |
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma |
| NCT06736717 |
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer |
| NCT07046585 |
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC) |
| NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
| NCT05977036 |
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer |
| NCT07189871 |
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors |
| NCT06982521 |
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer |
| NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
| NCT06257693 |
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer |
| NCT07158021 |
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial |
| NCT06115486 |
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer |
| NCT06072781 |
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer |
| NCT01954992 |
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer |
| NCT05056857 |
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen |
| NCT07549412 |
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) |
| NCT05827081 |
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
| NCT05417867 |
Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer |
| NCT05863195 |
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial |
| NCT07223411 |
Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma |
| NCT07102381 |
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer |
| NCT07124000 |
DESTINY-PANTUMOUR04 |
| NCT07085767 |
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer |
| NCT06666192 |
The Ohio State University (OSU) SCREEN Community Program |
| NCT04291612 |
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease |
| NCT03556228 |
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma |
| NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
| NCT07244341 |
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| NCT05896839 |
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer |
| NCT05234177 |
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays |
| NCT06158139 |
Autologous CAR-T Cells Targeting B7-H3 in PDAC |
| NCT01788839 |
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma |
| NCT05435495 |
Mechanisms of Resistance to PSMA Radioligand Therapy |
| NCT05903131 |
Uterine Preservation Via Lifestyle Transformation |
| NCT07145177 |
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer |
| NCT05564377 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial |
| NCT06879041 |
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT04420702 |
Diffusion Basis Spectrum Imaging of the Prostate |
| NCT07140172 |
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery |
| NCT07278986 |
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer |
| NCT03492151 |
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions |
| NCT05806515 |
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation |
| NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
| NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
| NCT06898996 |
FITting Non-invasive Tests in Lynch Syndrome Surveillance |
| NCT07649057 |
A Study of a Urine Test to Detect Colorectal Cancer |
| NCT04429542 |
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors |
| NCT06612281 |
Evaluation of Gixam's Performance in a FIT Negative Population |
| NCT03321045 |
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness |
| NCT02610439 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer |
| NCT06875128 |
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease |
| NCT06855654 |
Promoting Resilience in Women With Breast Cancer (PRISM -MBC) |
| NCT06479239 |
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer |
| NCT07564141 |
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer |
| NCT05704283 |
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer |
| NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
| NCT07675967 |
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study |
| NCT04144023 |
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ |
| NCT06224673 |
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer |
| NCT07181473 |
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors |
| NCT05011383 |
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers |
| NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
| NCT07567846 |
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer |
| NCT03096418 |
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response |
| NCT05877859 |
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab |
| NCT02926690 |
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer |
| NCT01503190 |
The Immune System's Response to Young Women's Breast Cancer |
| NCT05489211 |
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) |
| NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
| NCT07029399 |
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors |
| NCT07222215 |
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) |
| NCT05239338 |
Preserving Fertility After Colorectal Cancer Study |
| NCT05366699 |
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy |
| NCT00830557 |
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders |
| NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
| NCT07066657 |
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors |
| NCT07140900 |
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer |
| NCT06677112 |
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer |
| NCT06150664 |
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies |
| NCT07114939 |
FTT PET/CT in Pancreatic Neuroendocrine Tumors |
| NCT06395519 |
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies |
| NCT06258993 |
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation |
| NCT04489719 |
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer |
| NCT06637306 |
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer |
| NCT06394804 |
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer |
| NCT06260033 |
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer |
| NCT07223047 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies |
| NCT06149481 |
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) |
| NCT02012699 |
Integrated Cancer Repository for Cancer Research |
| NCT07644702 |
WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women |
| NCT06828588 |
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy |
| NCT04115254 |
Stereotactic Magnetic Resonance Guided Radiation Therapy |
| NCT06529822 |
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease |
| NCT05933395 |
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor |
| NCT06067841 |
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer |
| NCT07226856 |
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma |
| NCT06864754 |
WashU DIEP Flap Video and Patient Understanding Improvement |
| NCT07630402 |
Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer |
| NCT04683653 |
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer |
| NCT07631572 |
Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer |
| NCT06518746 |
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation |
| NCT07776353 |
Understanding New Cachexia Subtypes Through Observational Epidemiological Research |
| NCT07197554 |
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies |
| NCT06228053 |
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer |
| NCT07570979 |
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer |
| NCT04779554 |
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC |
| NCT00451022 |
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies |
| NCT07157033 |
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. |
| NCT05983432 |
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors |
| NCT07020221 |
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors |
| NCT07153614 |
Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy |
| NCT07165132 |
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. |
| NCT05422911 |
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. |
| NCT06401421 |
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) |
| NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer |
| NCT06465966 |
UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning |
| NCT04406831 |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer |
| NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
| NCT05561842 |
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries) |
| NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) |
| NCT05867251 |
Study of AVZO-021 in Patients With Advanced Solid Tumors |
| NCT03998202 |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer |
| NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT05259410 |
Time Restricted Eating During Chemotherapy for Breast Cancer |
| NCT07109427 |
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System |
| NCT07225270 |
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy |
| NCT07270237 |
A Study of Multiparametric Ultrasound Imaging Methods |
| NCT01521741 |
Prospective Screening for Breast Cancer-related Lymphedema |
| NCT06896162 |
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival |
| NCT07294703 |
Factors Associated With Breast Cancer Risks and Outcomes |
| NCT06120283 |
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors |
| NCT06096688 |
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction |
| NCT01000883 |
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior |
| NCT06481592 |
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. |
| NCT07635147 |
Decision Support Tool for Patients With Advanced Breast Cancer |
| NCT06423963 |
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer |
| NCT06974604 |
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM |
| NCT06290193 |
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery |
| NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
| NCT06926920 |
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer |
| NCT04586959 |
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer |
| NCT06179303 |
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer |
| NCT01530373 |
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients |
| NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
| NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
| NCT04886986 |
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer |
| NCT07454642 |
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors |
| NCT07522073 |
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT05557877 |
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer |
| NCT07059884 |
Distance-Based Exercise to Preserve Function and Prevent Disability |
| NCT07050771 |
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery |
| NCT04543071 |
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma |
| NCT06610539 |
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients |
| NCT05178498 |
Impact of Dietary Inflammatory Potential on Breast Cancer Risk |
| NCT06225011 |
Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer |
| NCT06617481 |
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence |
| NCT06993844 |
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors |
| NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. |
| NCT06881992 |
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism |
| NCT07226427 |
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer |
| NCT07694986 |
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD |
| NCT06378866 |
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial |
| NCT06062745 |
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT |
| NCT07413939 |
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive |
| NCT02926729 |
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy |
| NCT04794322 |
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer |
| NCT06217822 |
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| NCT07553572 |
Remote Monitoring and Symptom Management Digital Application |
| NCT05919329 |
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy |
| NCT07069556 |
ColoSense Post-Approval Study |
| NCT07153016 |
LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer |
| NCT00034216 |
Collection of Blood From Patients With Cancer |
| NCT04251052 |
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer |
| NCT07397338 |
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors |
| NCT06216938 |
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis |
| NCT07025785 |
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer |
| NCT03947385 |
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions |
| NCT06270043 |
Focal Therapy for Localized Prostate Cancer |
| NCT02620852 |
Women Informed to Screen Depending on Measures of Risk (Wisdom Study) |
| NCT05241249 |
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma |
| NCT06880549 |
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors |
| NCT07227038 |
Living Well With Advanced Breast Cancer |
| NCT05573126 |
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer |
| NCT07203378 |
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu |
| NCT07478016 |
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients |
| NCT06504914 |
Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors |
| NCT05190978 |
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction |
| NCT05125016 |
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer |
| NCT04473833 |
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer |
| NCT05417308 |
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer |
| NCT06205849 |
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer |
| NCT03151629 |
International Registry for Men With Advanced Prostate Cancer (IRONMAN) |
| NCT06807437 |
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula |
| NCT06599619 |
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi |
| NCT07736937 |
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer |
| NCT04239573 |
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers |
| NCT07005154 |
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer |
| NCT06940739 |
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel |
| NCT04196257 |
BP1001-A in Patients With Advanced or Recurrent Solid Tumors |
| NCT06543537 |
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer |
| NCT06263088 |
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. |
| NCT07646847 |
A Study of a Side Effects and Resource Navigation Program for People With Cancer |
| NCT01185132 |
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy |
| NCT07078604 |
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer |
| NCT06545604 |
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer |
| NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
| NCT06651359 |
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors |
| NCT05080946 |
Using Aspirin to Improve Immunological Features of Ovarian Tumors |
| NCT06672497 |
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients |
| NCT04692818 |
3D Ultrasound Breast Imaging |
| NCT06682650 |
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics) |
| NCT07308717 |
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol |
| NCT07053085 |
A Study of Surgery and Radiotherapy in People With Breast Cancer |
| NCT07524855 |
A Study of HLD-0117 in Patients With Metastatic Breast Cancer |
| NCT06425926 |
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors |
| NCT06926868 |
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) |
| NCT05256225 |
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma |
| NCT07213791 |
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors |
| NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |
| NCT07313306 |
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise |
| NCT06428409 |
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) |
| NCT06605404 |
Pan-tumor MRD Study |
| NCT06252649 |
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation |
| NCT05914116 |
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
| NCT03053193 |
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles |
| NCT06526819 |
SMP-3124LP in Adults With Advanced Solid Tumors |
| NCT03250078 |
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals |
| NCT06542835 |
Community Partnership for Telehealth Solutions to Convey Information and Enhance Care |
| NCT07559825 |
Early-Onset Colorectal Cancer Patients Too Young for Screening |
| NCT07213804 |
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer |
| NCT03384238 |
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery |
| NCT07226115 |
Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer |
| NCT06938555 |
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors |
| NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
| NCT05595499 |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
| NCT07454499 |
Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE) |
| NCT05743621 |
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer |
| NCT06943521 |
A Study of MT-4561 in Patients With Various Advanced Solid Tumors |
| NCT07213609 |
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors |
| NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
| NCT07219303 |
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer |
| NCT07550088 |
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases |
| NCT05629494 |
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test |
| NCT05307705 |
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors |
| NCT07283705 |
A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer |
| NCT05318469 |
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer |
| NCT06239194 |
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors |
| NCT01102556 |
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease |
| NCT07396766 |
Dissemination of BREASTChoice AIM1-B |
| NCT06710756 |
Lead-212 PSV359 Therapy for Patients With Solid Tumors |
| NCT06040970 |
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer |
| NCT06568562 |
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
| NCT07671339 |
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer |
| NCT07645651 |
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer |
| NCT07696572 |
EUS Procedures Using RIVOS™ EUS Access Device |
| NCT07146568 |
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital |
| NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
| NCT05413850 |
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection |
| NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
| NCT04512144 |
Mindfulness in Endometrial and Cervical Cancer |
| NCT04693377 |
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial |
| NCT03863457 |
[18F] F-GLN by PET/CT in Breast Cancer |
| NCT06927895 |
Breast Cancer Implementation Science Study With Educational Intervention |
| NCT05900895 |
Estradiol Plus Olaparib for Breast Cancer (PHOEBE) |
| NCT00843375 |
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas |
| NCT04633239 |
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer |
| NCT05379595 |
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer |
| NCT04520139 |
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT |
| NCT06892275 |
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI |
| NCT07409272 |
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer |
| NCT07307664 |
Increasing Germline Genetic Testing for Patients With Cancer |
| NCT03711890 |
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer |
| NCT07254910 |
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma |
| NCT07764133 |
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer |
| NCT04841148 |
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer |
| NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
| NCT05720338 |
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? |
| NCT05313191 |
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors |
| NCT06598007 |
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors |
| NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
| NCT05517811 |
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection |
| NCT04598009 |
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma |
| NCT07009093 |
Utility of a Mobile Application for Young Women With Breast Cancer |
| NCT07095114 |
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. |
| NCT06216249 |
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) |
| NCT06004245 |
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors |
| NCT06336902 |
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer |
| NCT05039801 |
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors |
| NCT06721065 |
A Study of Language Interpretation Solutions for People With Breast Cancer |
| NCT06139107 |
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole |
| NCT05438511 |
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania |
| NCT05751434 |
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
| NCT06228599 |
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence |
| NCT04990921 |
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
| NCT07651358 |
A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy |
| NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
| NCT04594187 |
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma |
| NCT05123807 |
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) |
| NCT05887609 |
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib |
| NCT07361614 |
Pilot Testing of a Colorectal Cancer Education Program |
| NCT07048314 |
Stem Cells for Erectile Dysfunction Post RALP |
| NCT05155033 |
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma |
| NCT04992728 |
Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI |
| NCT06778863 |
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation |
| NCT04914663 |
All-extremity Exercise During Breast Cancer Chemotherapy |
| NCT07235293 |
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. |
| NCT07360314 |
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors |
| NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
| NCT07458347 |
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation |
| NCT06819007 |
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) |
| NCT07320664 |
Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women |
| NCT03968406 |
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers |
| NCT07354919 |
Axelopran for Advanced Cancer in Patients Receiving Opioids |
| NCT07044336 |
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) |
| NCT06750484 |
Trial of Trastuzumab Deruxtecan in Previously Treated HER2 |
| NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
| NCT05115474 |
Study of Screening Brain MRIs in Stage IV Breast Cancer |
| NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
| NCT07504835 |
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer |
| NCT06437574 |
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer |
| NCT06682390 |
Role of Race in Nutritional Approach in Men on ADT |
| NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
| NCT06922591 |
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients |
| NCT05610852 |
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound |
| NCT05719558 |
A Study of ASP1002 in Adults for Treatment of Solid Tumors |
| NCT07287917 |
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors |
| NCT07070726 |
UNTOLD Ovarian Cancer Unmet Needs Survey |
| NCT05386108 |
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer |
| NCT05780814 |
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer |
| NCT06615752 |
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients |
| NCT06129747 |
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast |
| NCT04907643 |
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
| NCT06915025 |
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer |
| NCT00912717 |
Pancreatic Adenocarcinoma Gene Environment Risk Study |
| NCT05254171 |
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer |
| NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling |
| NCT06006806 |
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy |
| NCT06332755 |
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC |
| NCT06743126 |
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma |
| NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
| NCT07460752 |
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients |
| NCT07527858 |
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer |
| NCT07446322 |
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer |
| NCT06954337 |
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial |
| NCT07258407 |
A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer |
| NCT07059845 |
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer |
| NCT07142967 |
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II) |
| NCT01776905 |
In Vivo Real-time Detection of Circulating Melanoma Cells |
| NCT07393867 |
Androgen-responsive POSLUMA-guided Intra-prostatic Boost |
| NCT07111507 |
A Study of Tarlatamab for People With Prostate Cancer |
| NCT06103669 |
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) |
| NCT05856981 |
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors |
| NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
| NCT07341867 |
Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype |
| NCT05647564 |
PET/CT Characterization of Treatment Resistance |
| NCT04895709 |
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors |
| NCT05469269 |
Cleveland African American Prostate Cancer Project |
| NCT02253251 |
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment |
| NCT06026657 |
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer |
| NCT07185165 |
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. |
| NCT05694559 |
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics |
| NCT07562152 |
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma |
| NCT06959550 |
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer |
| NCT04765150 |
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification |
| NCT04792684 |
Collection of Samples USOPTIVAL Study |
| NCT05989347 |
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy |
| NCT07276438 |
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial |
| NCT06401889 |
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy |
| NCT06780176 |
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida |
| NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
| NCT06686043 |
HPV Vaccine, Imiquimod, and Metformin Combination Trial |
| NCT06586515 |
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors |
| NCT05691010 |
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer |
| NCT07277413 |
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors |
| NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
| NCT07335224 |
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture |
| NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
| NCT07287150 |
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT05373823 |
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors |
| NCT07619313 |
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer |
| NCT03784924 |
EDRN Prostate MRI Biomarker Study |
| NCT07595874 |
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 |
| NCT06412510 |
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT |
| NCT06551220 |
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns |
| NCT07219147 |
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT07211178 |
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies |
| NCT02896335 |
Palbociclib and Pembrolizumab In Central Nervous System Metastases |
| NCT06827613 |
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors |
| NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
| NCT07749586 |
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors |
| NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. |
| NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
| NCT07745361 |
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer |
| NCT05899361 |
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest |
| NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
| NCT06117241 |
Reducing Metabolic Dysregulation in Dyads |
| NCT07042581 |
A Study of Revaree Plus in People With Breast Cancer |
| NCT06856694 |
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer |
| NCT04494945 |
Identifying and Caring for Individuals With Inherited Cancer Syndrome |
| NCT05989828 |
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer |
| NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
| NCT04423211 |
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging |
| NCT05952453 |
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro |
| NCT05077137 |
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy |
| NCT05248581 |
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases |
| NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
| NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
| NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
| NCT04888975 |
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery |
| NCT03972657 |
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors |
| NCT05950945 |
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer |
| NCT06841354 |
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) |
| NCT05579366 |
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
| NCT05092373 |
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax |
| NCT05913388 |
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma |
| NCT05005403 |
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan |
| NCT07071961 |
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] |
| NCT07082920 |
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer |
| NCT07049276 |
The Multicentre Selective Lymphadenectomy Trial - 3 |
| NCT05946824 |
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. |
| NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
| NCT06246968 |
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer |
| NCT05946213 |
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer |
| NCT04763980 |
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer |
| NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
| NCT06887205 |
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study |
| NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial |
| NCT02393703 |
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer |
| NCT06511141 |
Sacral Neuromodulation for Male Overactive Bladder (MOAB) |
| NCT05518903 |
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma |
| NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
| NCT03190941 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients |
| NCT07237594 |
IL-17 Blockade to Decrease irAEs (REPLAY) |
| NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
| NCT06654037 |
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer |
| NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
| NCT06101290 |
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) |
| NCT05463796 |
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer |
| NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
| NCT06084013 |
Use Of Indocyanine Green In Pancreas Surgery |
| NCT06603597 |
HER2-positive Breast Cancer Registry |
| NCT06783179 |
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement |
| NCT06445062 |
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors |
| NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
| NCT07502352 |
Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM) |
| NCT07441889 |
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) |
| NCT07313241 |
Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER) |
| NCT05716516 |
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) |
| NCT07447050 |
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial |
| NCT06246149 |
Adjuvant Tebentafusp in High Risk Ocular Melanoma |
| NCT06610825 |
Castrate Resistant Prostate Cancer Enhertu Therapy |
| NCT07544589 |
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers |
| NCT07123649 |
Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study |
| NCT06265285 |
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program |
| NCT06607458 |
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease |
| NCT05037825 |
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors |
| NCT06412198 |
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations |
| NCT06726148 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors |
| NCT07621614 |
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information |
| NCT04513028 |
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma |
| NCT04084730 |
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer |
| NCT06888102 |
A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer |
| NCT04329494 |
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer |
| NCT03808337 |
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease |
| NCT05824975 |
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) |
| NCT04981119 |
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing |
| NCT06545045 |
Cognitive Rehabilitation Following Breast Cancer Treatment |
| NCT04722341 |
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators |
| NCT05071937 |
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer |
| NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
| NCT07018869 |
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors |
| NCT06172283 |
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
| NCT06593431 |
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial |
| NCT06833502 |
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer |
| NCT06055881 |
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy |
| NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
| NCT03860883 |
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma |
| NCT06833853 |
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients |
| NCT06563388 |
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial |
| NCT04485286 |
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury |
| NCT07546331 |
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction |
| NCT07276386 |
Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma |
| NCT03954431 |
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT) |
| NCT06545331 |
Study of XB010 in Subjects With Solid Tumors |
| NCT06500169 |
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors |
| NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
| NCT07542041 |
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens |
| NCT05630794 |
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 |
| NCT06022822 |
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial |
| NCT06959537 |
A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC) |
| NCT07652242 |
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer |
| NCT05655494 |
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials |
| NCT06673329 |
Brodalumab in the Treatment of Immune-Related Adverse Events |
| NCT07723248 |
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) |
| NCT06798558 |
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy |
| NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
| NCT04913064 |
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer |
| NCT07220863 |
Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai |
| NCT06710548 |
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors |
| NCT04816006 |
Breast Cancer, Reasoning, and Activity Intervention |
| NCT07172282 |
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases |
| NCT06990880 |
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer |
| NCT05585788 |
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients |
| NCT06727773 |
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer |
| NCT05803941 |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
| NCT06807359 |
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System |
| NCT06386146 |
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation |
| NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
| NCT06202820 |
CV CARE: CardioVascular Care in PC Patients |
| NCT07214779 |
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression |
| NCT04658303 |
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma |
| NCT05231122 |
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer |
| NCT05111561 |
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer |
| NCT07407959 |
Screening and Staging of Benign vs Malignant Pelvic Abnormalities |
| NCT07225946 |
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT05429970 |
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) |
| NCT01365169 |
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" |
| NCT07300150 |
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors |
| NCT07201376 |
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically |
| NCT07011576 |
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL) |
| NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
| NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
| NCT04903119 |
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma |
| NCT06744465 |
NearWave Optical Molecular Monitoring |
| NCT06238921 |
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases |
| NCT05743049 |
Collection of Circulating Biomarkers in Pancreatic Cancer |
| NCT06789653 |
A Novel Approach Utilizing Organ Specific Age Proteomics |
| NCT07090499 |
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors |
| NCT04920032 |
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas |
| NCT06961006 |
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) |
| NCT05716893 |
Study of Aerobic Training for People Receiving Treatment for Breast Cancer |
| NCT07158164 |
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment |
| NCT05608252 |
VS-6766+Abema+Fulv in Met HR+/HER- BC |
| NCT07213674 |
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer |
| NCT06398418 |
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors |
| NCT06075810 |
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer |
| NCT07790718 |
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer |
| NCT06492759 |
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer |
| NCT01000259 |
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer |
| NCT06130280 |
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer |
| NCT05799274 |
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors |
| NCT05979610 |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies |
| NCT03567889 |
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients |
| NCT06245889 |
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC |
| NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
| NCT05014399 |
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy |
| NCT07208084 |
Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer |
| NCT07383506 |
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors |
| NCT07192614 |
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer |
| NCT05705492 |
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer |
| NCT04847063 |
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies |
| NCT04893109 |
ATEMPT 2.0: Adjuvant T-DM1 vs TH |
| NCT05918263 |
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial |
| NCT06763328 |
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy |
| NCT06101277 |
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) |
| NCT06072807 |
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer |
| NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
| NCT05795101 |
TRUDI: TDXD+Durva in HER2+/Low IBC |
| NCT06625775 |
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors |
| NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
| NCT07103018 |
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001) |
| NCT07621718 |
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) |
| NCT05746897 |
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors |
| NCT07122713 |
Definitive Radiation Therapy for Inoperable Breast Cancer |
| NCT07555210 |
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy |
| NCT04812912 |
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer |
| NCT06055439 |
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy |
| NCT07207564 |
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk |
| NCT04897321 |
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) |
| NCT05888532 |
64Cu-GRIP B in Patients With Advanced Malignancies |
| NCT07759921 |
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer |
| NCT01913106 |
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
| NCT06960707 |
Two Versus One Week Breast Radiotherapy (RT) |
| NCT06565052 |
The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial |
| NCT07690917 |
A Study of a New PET Scanner in People With Cancer |
| NCT07345676 |
Colorectal Cancer Screening Outreach |
| NCT07191717 |
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial |
| NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
| NCT04946370 |
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer |
| NCT07556380 |
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions |
| NCT07594015 |
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Failure of First-Line Therapy With Platinum-based Doublet and Immunotherapy |
| NCT07335796 |
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer |
| NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy |
| NCT07662824 |
Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy |
| NCT06650579 |
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial |
| NCT06545682 |
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) |
| NCT06966388 |
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation |
| NCT07223424 |
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy |
| NCT05074290 |
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients |
| NCT03877796 |
Clinical Pre-screening Protocol for Ovarian Cancer |
| NCT03897270 |
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects |
| NCT05646862 |
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy |
| NCT05758688 |
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer |
| NCT07690579 |
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities |
| NCT06960798 |
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) |
| NCT04526587 |
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors |
| NCT07525206 |
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer |
| NCT06105684 |
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer |
| NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
| NCT05780684 |
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer |
| NCT02598349 |
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas |
| NCT06298734 |
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial |
| NCT04486352 |
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer |
| NCT04230109 |
Sacituzumab Govitecan In TNBC |
| NCT04706663 |
Precision-Based Genomics in Prostate Cancer |
| NCT07489287 |
GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer |
| NCT04489238 |
Collection of Information to Better Understand Young Onset Colorectal Cancer |
| NCT07543757 |
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix |
| NCT06686394 |
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) |
| NCT06867822 |
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer |
| NCT06398639 |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
| NCT05396612 |
Role of the Immune Environment in Response to Therapy in Breast Cancer |
| NCT06342401 |
Early Onset Colorectal Cancer Detection |
| NCT01950572 |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma |
| NCT05219695 |
Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) |
| NCT05915442 |
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer |
| NCT06750094 |
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy |
| NCT05804318 |
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer |
| NCT07044310 |
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss |
| NCT07659795 |
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer |
| NCT07093177 |
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer |
| NCT03067051 |
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System |
| NCT05774951 |
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy |
| NCT05398302 |
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy |
| NCT05253651 |
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer |
| NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
| NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
| NCT07069595 |
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease |
| NCT07055165 |
Connect2Care: Prostate Cancer Education and Screenings for African American Men |
| NCT06520345 |
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) |
| NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
| NCT06673017 |
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT07426952 |
Weight Management After Cancer for Survivors in Rural Communities |
| NCT07594106 |
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma |
| NCT07115043 |
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors |
| NCT06953089 |
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors |
| NCT03334708 |
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma |
| NCT04362826 |
Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer |
| NCT06555133 |
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC |
| NCT07427043 |
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES) |
| NCT06710288 |
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer |
| NCT06284590 |
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients |
| NCT05968690 |
Naltrexone and Propranolol Combined With Immunotherapy |
| NCT07216560 |
First-in-human Study of 7MW4911 in GI Cancer |
| NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
| NCT06592924 |
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response |
| NCT07746713 |
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer |
| NCT06616597 |
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer |
| NCT06636123 |
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy |
| NCT07106359 |
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome |
| NCT05497024 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing |
| NCT07029490 |
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study |
| NCT05512208 |
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib |
| NCT06957691 |
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy |
| NCT07084779 |
Investigation of Impact of AI on Prostate Cancer Workflow |
| NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
| NCT07361562 |
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors |
| NCT06148038 |
CBD for Breast Cancer Primary Tumors |
| NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
| NCT05616650 |
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor |
| NCT07020117 |
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors |
| NCT06957535 |
Community-led Navigation to Address Disparities in Mammography Among Native American Women |
| NCT01766297 |
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer |
| NCT07238023 |
Promoting Active Living Among People With Metastatic Breast Cancer |
| NCT06130826 |
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer |
| NCT05365581 |
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer |
| NCT06658912 |
Planning Grant for TOPS for Breast Cancer Survivors |
| NCT06488365 |
In Vivo Liquid Biopsy of Melanoma (Cytophone) |
| NCT04354064 |
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors |
| NCT07476001 |
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC |
| NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
| NCT06085664 |
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy |
| NCT04919629 |
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion |
| NCT06965192 |
Designing Visual Tools to Enhance Cancer Surgeon Decision-making |
| NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
| NCT03937453 |
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus |
| NCT03539822 |
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies |
| NCT07114601 |
A Study of LY4257496 in Participants With Cancer (OMNIRAY) |
| NCT07124611 |
A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer |
| NCT05805371 |
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer |
| NCT07030907 |
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer |
| NCT07628634 |
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors |
| NCT07066189 |
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC |
| NCT07634380 |
Sitagliptin With Pembro in RCC and Melanoma |
| NCT05948657 |
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr |
| NCT06138067 |
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients |
| NCT03424005 |
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer |
| NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
| NCT06144164 |
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer |
| NCT06434064 |
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer |
| NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer |
| NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
| NCT05534646 |
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
| NCT06234423 |
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors |
| NCT05128890 |
Evaluation of Resection Techniques for Pancreatic Tumors |
| NCT06353997 |
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients |
| NCT07751042 |
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
| NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
| NCT07214610 |
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study |
| NCT06173362 |
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer |
| NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
| NCT06128551 |
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors |
| NCT07427394 |
Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer |
| NCT06574022 |
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks |
| NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
| NCT04545957 |
Jump: MR Simulation For Radiation Therapy Master Protocol |
| NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
| NCT02422641 |
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis |
| NCT07075731 |
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy |
| NCT06802172 |
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial |
| NCT06150417 |
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) |
| NCT06613100 |
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer |
| NCT07702032 |
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) |
| NCT06731998 |
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery |
| NCT06999798 |
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial |
| NCT05902507 |
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer |
| NCT07636200 |
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer |
| NCT07058012 |
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) |
| NCT05741164 |
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer |
| NCT06771544 |
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma |
| NCT04363164 |
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression |
| NCT06249048 |
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
| NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
| NCT07224425 |
A Study of BI 3810944 in Patients With Advanced Cancer |
| NCT03604315 |
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF |
| NCT05624918 |
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma |
| NCT06817226 |
BREAST Choice Decision Tool R21 - AIM2 |
| NCT07090148 |
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC |
| NCT06931340 |
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial |
| NCT06826768 |
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC |
| NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
| NCT05974150 |
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring |
| NCT07206121 |
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery |
| NCT04701476 |
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC |
| NCT07660055 |
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors |
| NCT05919108 |
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
| NCT06409052 |
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women |
| NCT07126158 |
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma |
| NCT03678025 |
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer |
| NCT05727904 |
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
| NCT04516447 |
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer |
| NCT05997017 |
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer |
| NCT06581406 |
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma |
| NCT07042685 |
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer |
| NCT02016248 |
SBRT Boost for Unfavorable Prostate Cancer' |
| NCT07227233 |
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. |
| NCT06756035 |
CT-95 in Advanced Cancers Associated With Mesothelin Expression |
| NCT07202247 |
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial |
| NCT06887348 |
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 |
| NCT06559540 |
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer |
| NCT06361940 |
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer |
| NCT07546500 |
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression |
| NCT06981208 |
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction |
| NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
| NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
| NCT06555588 |
Engage Psychosocial Intervention for Cancer Symptoms |
| NCT06340646 |
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) |
| NCT07027488 |
AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT06946225 |
ACTengine® IMA203 Combined With mRNA-4203 |
| NCT07463833 |
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology |
| NCT03878849 |
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer |
| NCT05879926 |
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 |
| NCT05029999 |
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer |
| NCT05472792 |
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy |
| NCT02997293 |
Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery |
| NCT07227077 |
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial |
| NCT06008275 |
Neratinib in Combination With Ruxolitinib in Patients With mTNBC |
| NCT07073794 |
Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer |
| NCT00756665 |
Prostate Active Surveillance Study |
| NCT03823144 |
Intravital Microscopy in Human Solid Tumors |
| NCT06764771 |
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors |
| NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
| NCT07222800 |
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer |
| NCT07447700 |
A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer |
| NCT05379153 |
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial |
| NCT07491445 |
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma |
| NCT07443943 |
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial |
| NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
| NCT04590326 |
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab |
| NCT05546827 |
Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma |
| NCT07492927 |
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer |
| NCT06472661 |
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma |
| NCT04294927 |
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention |
| NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
| NCT04038502 |
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer |
| NCT07205822 |
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer |
| NCT06538337 |
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers |
| NCT06666439 |
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer |
| NCT05376592 |
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma |
| NCT06169371 |
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) |
| NCT06757192 |
CRC Screening in Unscreened Individuals 45-54 |
| NCT07190300 |
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
| NCT06134375 |
A Study of Tetrathiomolybdate (TM) Plus Capecitabine |
| NCT03943316 |
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies |
| NCT06600906 |
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer |
| NCT07020806 |
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) |
| NCT06831071 |
Evaluation of Hypoxia in Primary Melanoma |
| NCT06907446 |
Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies |
| NCT07310420 |
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer |
| NCT06220214 |
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer |
| NCT05676255 |
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project |
| NCT07636785 |
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors |
| NCT06562543 |
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer |
| NCT06297525 |
Study of STP938 (Dencatistat) in Advanced Solid Tumours |
| NCT07067138 |
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast) |
| NCT06922318 |
The COSMYC Trial (COmbined Suppression of MYC) |
| NCT06059118 |
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer |
| NCT06423326 |
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer |
| NCT06217874 |
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer |
| NCT07690852 |
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care |
| NCT05985655 |
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors |
| NCT05990426 |
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy |
| NCT07042243 |
The Florida ASCENT Study |
| NCT05508906 |
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer |
| NCT06365619 |
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma |
| NCT04995198 |
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness |
| NCT07739563 |
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer |
| NCT06580314 |
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer |
| NCT06450106 |
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy |
| NCT06064149 |
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study |
| NCT06422455 |
Access to Genetic Testing in Underserved Patients With Cancer |
| NCT07223385 |
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) |
| NCT04553770 |
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer |
| NCT06515470 |
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer |
| NCT07182149 |
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors |
| NCT05519449 |
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) |
| NCT06065748 |
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) |
| NCT06085729 |
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) |
| NCT04616131 |
Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy |
| NCT06855277 |
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC |
| NCT07318415 |
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer |
| NCT07224815 |
cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer |
| NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
| NCT06044025 |
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy |
| NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer |
| NCT06391034 |
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer |
| NCT05504707 |
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer |
| NCT07137871 |
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy |
| NCT00477100 |
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer |
| NCT06110793 |
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer |
| NCT06377852 |
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study |
| NCT07432633 |
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications |
| NCT06878547 |
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients |
| NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
| NCT07055854 |
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors |
| NCT07318805 |
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors |
| NCT07524322 |
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors |
| NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
| NCT07581184 |
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT06205836 |
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer |
| NCT07143487 |
Family Communications After Genetic Testing |
| NCT06706921 |
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer |
| NCT05406232 |
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer |
| NCT06517212 |
Tirzepatide Weight Loss for MRD+ Early Breast Cancer |
| NCT06065371 |
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy |
| NCT04701645 |
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer |
| NCT07095517 |
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors |
| NCT03620786 |
HIFU for Focal Ablation of Prostate Tissue: An Observational Study |
| NCT04332588 |
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI |
| NCT06218303 |
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ |
| NCT06705803 |
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE) |
| NCT07226986 |
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC |
| NCT06728579 |
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors |
| NCT07087691 |
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance |
| NCT06636682 |
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
| NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
| NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
| NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
| NCT07544680 |
Endometrial Cancer Vaginal Fluid Specimen Collection Study |
| NCT04904757 |
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening |
| NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
| NCT03934905 |
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction |
| NCT03396341 |
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes |
| NCT06591819 |
Hypofractionated WPPT With HDR Boost |
| NCT06384222 |
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone |
| NCT03412877 |
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer |
| NCT06121453 |
Adherence Intervention in Patients With Metastatic Breast Cancer |
| NCT06934239 |
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients |
| NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
| NCT06885203 |
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI) |
| NCT06952803 |
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation |
| NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
| NCT03451383 |
Older Breast Cancer Patients: Risk for Cognitive Decline |
| NCT07481383 |
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer |
| NCT07426822 |
Rash & Diarrhea Prophylaxis With Capivasertib |
| NCT06075953 |
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment |
| NCT05652686 |
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) |
| NCT06792695 |
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer |
| NCT07228000 |
Bundled Cancer Screening and Genetic Services Navigation |
| NCT05144698 |
RAPA-201 Therapy of Solid Tumors |
| NCT05283330 |
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors |
| NCT07200830 |
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial |
| NCT05086692 |
A Beta-only IL-2 ImmunoTherapY Study |
| NCT06941857 |
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer |
| NCT04275557 |
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| NCT05218044 |
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ |
| NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
| NCT07319871 |
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer |
| NCT06405828 |
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer |
| NCT06638307 |
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer |
| NCT06318507 |
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy |
| NCT06674811 |
Biomarkers of Resiliency In Childhood Cancer Surgery |
| NCT02333604 |
Cancer Experience Registry (CER) for Cancer Patients and Caregivers |
| NCT06720987 |
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies |
| NCT06414733 |
HER-2 B Cell Peptide Vaccine |
| NCT06340568 |
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer |
| NCT06833255 |
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York |
| NCT02918474 |
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer |
| NCT06369610 |
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer |
| NCT05040360 |
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors |
| NCT06111313 |
The University of Miami Adapt (UAdapt) Trial |
| NCT06312124 |
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer |
| NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
| NCT06173310 |
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer |
| NCT06199713 |
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients |
| NCT05620329 |
UNC Pleural Fluid Registry |
| NCT07079631 |
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer |
| NCT02594202 |
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue |
| NCT05800665 |
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer |
| NCT07332000 |
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec |
| NCT07500012 |
taVNS for Breast Cancer Pain and Symptom Management |
| NCT07594067 |
TCR1188-ABC Cells in KRAS-mutated Cancers |
| NCT06178354 |
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer |
| NCT05768139 |
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors |
| NCT05315700 |
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration |
| NCT05625659 |
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts |
| NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
| NCT06096870 |
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy |
| NCT06910670 |
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid |
| NCT05746182 |
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms |
| NCT06136624 |
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) |
| NCT04421820 |
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours |
| NCT05208762 |
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors |
| NCT07231627 |
AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions |
| NCT07554560 |
Nutrition Intervention for Pancreatic Cancer |
| NCT06949410 |
HER2 Vaccine for Locally Advanced Breast Cancer |
| NCT05548296 |
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma |
| NCT06176261 |
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs |
| NCT05223803 |
TERPS Trial for de Novo Oligometastic Prostate Cancer |
| NCT00001823 |
Evaluation for NCI Surgery Branch Clinical Research Protocols |
| NCT07612046 |
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening |
| NCT05586360 |
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer |
| NCT04916990 |
Improving Care for Rural Patients With Solid Tumors |
| NCT05507879 |
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer |
| NCT06984562 |
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer |
| NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer |
| NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] |
| NCT06534918 |
Precise Oncology Interventions in Nutrition and Training (OnPoint) |
| NCT06541210 |
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men |
| NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies |
| NCT06589440 |
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) |
| NCT06161025 |
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
| NCT07488676 |
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors |
| NCT07332975 |
ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC |
| NCT06948448 |
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer |
| NCT03526835 |
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors |
| NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer |
| NCT07137416 |
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer |
| NCT07705334 |
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors |
| NCT04969315 |
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors |
| NCT06324240 |
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer |
| NCT06274047 |
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. |
| NCT03809585 |
Observational Study of Iris Tumors |
| NCT06095089 |
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer |
| NCT05950464 |
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer |
| NCT03659448 |
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer |
| NCT05786664 |
Breast Cancer Survivorship Biorepository |
| NCT07137468 |
Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk |
| NCT06824064 |
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer |
| NCT07038785 |
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs |
| NCT06898333 |
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening |
| NCT06617858 |
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment |
| NCT06983743 |
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors |
